Orient Pharma Co (4166.TWO) Stock Price
Orient Pharma Co Price
Revenue has compounded at 19.3% per year over the past 15 years to 1.40 B TWD. Earnings per share have grown at 193.0% per year over the last 2 years. Orient Pharma Co's net margin stands at 14.9%, up from -22.2% several years earlier.
Orient Pharma Co stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Orient Pharma Co business model & stock analysis
Frequently asked questions about Orient Pharma Co
Converted at the current exchange rate, the Orient Pharma Co share trades at 0.64 EUR (23.40 TWD).
The revenue cannot currently be calculated for Orient Pharma Co.
The profit cannot currently be calculated for Orient Pharma Co.
The P/E ratio cannot be calculated for Orient Pharma Co at the moment.
The P/S cannot be calculated for Orient Pharma Co currently.
The Eulerpool Quality Score for Orient Pharma Co is 6/10.
The ISIN of Orient Pharma Co is TW0004166004. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Orient Pharma Co is 4166.TWO. The ticker symbol is used to trade Orient Pharma Co shares on the stock exchange.
Orient Pharma Co stock
Orient Pharma Co Peer Group
Orient Pharma Co FIGI
All fundamentals and in-depth analysis of Orient Pharma Co
Our stock analysis for Orient Pharma Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Orient Pharma Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.